Key statistics
On Friday, Traws Pharma Inc (0T2:DUS) closed at 0.26, 0.00% above its 52-week low of 0.26, set on Sep 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.26 |
Low | 0.26 |
Bid | -- |
Offer | -- |
Previous close | 6.50 |
Average volume | -- |
---|---|
Shares outstanding | 1.83m |
Free float | 1.83m |
P/E (TTM) | -- |
Market cap | 8.77m USD |
EPS (TTM) | -138.17 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:30 BST.
More ▼
Announcements
- Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
- Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
- Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
- Traws Pharma, Inc. Announces Special Shareholders Meeting Results
- Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
- Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
- Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
- Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
- Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
- Traws Pharma Announces New Employee Inducement Grants
More ▼